New use for alcohol aversion drug in treatment of chemo resistant lung cancer found
(Trinity College Dublin) Scientists have had positive results from a laboratory-based study using a well-known alcohol aversion drug to try to combat chemotherapy resistance in the most common type of lung cancer, non-small cell lung cancer (NSCLC).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Alcoholism | Cancer | Cancer & Oncology | Chemotherapy | Laboratory Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Study